SPOTLIGHT -
Take a look at the therapies that have already reached the market.
Pearls for management of Pseudomonas scleritis
Dr Zeba A. Syed emphasises the importance of performing surgery sooner rather than later for patients with Pseudomonas scleritis
Federal investment and regulatory benefits draw biotech firms to Switzerland
The country is home to 20% of biotechs headquartered in Europe.
Preservative-free latanoprost as effective as BAK-preserved latanoprost
Therapeutic has fewer adverse effects in patients with POAG and OHT, study results show
UK patients with vision loss confused by ‘disjointed’ benefits registration system
Accessibility obstacles could prevent those with sight loss from receiving support and care.
Late spring heatwave poses vision risk to populations across Europe
What ophthalmologists want patients to know ahead of UK bank holiday.
Stating the facts about combination myopia management treatments
Growing evidence supports dual therapy to slow progression.
